FDA Inspection 1235038 — Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited — FEI 3014595023

The FDA completed an inspection of Emcure Pharmaceuticals Limited on Apr 5, 2024 in Ahmedabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 5, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ahmedabad (India)

Citations

IDCFRDescription
361321 CFR 211.160(b)(4)Establishment of calibration procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.